We’re one of the first firms to deliver coverage of foreign growth companies tailored specifically to U.S. investors.

Research Reports

Our research reports are available to our clients. If you are an existing client and already have a username and password, please login. If you are an existing client and want to register for access to the site, please use the registration form below.

If you are a potential client and are interested in finding out how Chardan can help you, please contact Shai Gerson at 646-465-9008.

Datesort icon Company Title Sector Symbol Rating Analyst Document
September 15, 2014 Rockwell Medical Inc. Zerenex's Label Highlights the Benefit of Triferic. Reiterate Buy. Biotechnology & Pharmaceuticals RMTI Buy Ling Wang Log In or Register
September 15, 2014 Chardan Global Insights - Sep 15 2014 RMTI Chardan Capital Markets Research Log In or Register
September 12, 2014 Medivation Inc Xtandi Gained Label Expansion, Raising PT to $122. Biotechnology & Pharmaceuticals MDVN Buy Ling Wang Log In or Register
September 12, 2014 Chardan Global Insights - Sep 12 2014 MDVN Chardan Capital Markets Research Log In or Register
September 9, 2014 iPass Inc. Exploring Strategic Alternatives Agriculture Technology IPAS Buy JAMES McILREE, CFA Log In or Register
September 9, 2014 Hemispherx Biopharma Inc HEB and USAMRIID collaborate on developing Alferon(R) against Ebola. Biotechnology & Pharmaceuticals HEB Buy Ling Wang Log In or Register
September 9, 2014 Max Linear Inc. Lowers Q3:14 Guidance on Weak Cable Revs;Lowering PT to $7.50;Reiterate Neutral Technology MXL Neutral Jay Srivatsa Log In or Register
September 9, 2014 Chardan Global Insights - Sep 09 2014 HEB IPAS MXL Chardan Capital Markets Research Log In or Register
September 8, 2014 Profire Energy Inc. Reiterate Buy and $5.80 Target. Strong Momentum Continues. Telecom Services PFIE Buy JAMES McILREE, CFA Log In or Register
September 5, 2014 Ambarella Inc. Impressive Q2:15 Results and Guidance; Raising Price Target to $35.00 Technology AMBA Neutral Jay Srivatsa Log In or Register

Coverage Universe

April 1, 2014

To learn more about our Research Group, please contact Jay Srivatsa at 646-465-9065